Cassava’s Simufilam Continues To Alienate Investors Despite Some Phase II Alzheimer’s Promise

 
• By Ayisha Sharma
  
Businessman walking on animated red arrow that is pointing diagonal and downwards
Simufilam's Efficacy Has Been Declining With Each Data Release • Source: Shutterstock

More from Neurological

More from Therapy Areas